TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24991883

Group type: COMPARATOR
Intervention: Infrared-C radiation hot compresses (IR-C HC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hot compresses (HC)
Number of subjects: 0
Study: 24220538

Group type: EXPERIMENTAL
Intervention: Mindfulness and acceptance-based group therapy (MAGT)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (CBGT)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 137
Study: 21296441

Group type: EXPERIMENTAL
Intervention: Whole breast radiotherapy using 3D dosimetry
Number of subjects: 279
Study: 19717572

Group type: EXPERIMENTAL
Intervention: Sports camp with six months of support from a local sports club
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 76

Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 76
Study: 17503982

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Social Skills Training (CBSST)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 76
Study: 16376251

Group type: EXPERIMENTAL
Intervention: Tourniquet release before wound closure
Number of subjects: 55

Group type: COMPARATOR
Intervention: Tourniquet release after wound closure
Number of subjects: 55
Study: 11669483

Group type: EXPERIMENTAL
Intervention: Gum group (sorbitol-sweetened chewing gum)
Number of subjects: 547

Group type: COMPARATOR
Intervention: Control group (no gum)
Number of subjects: 547
Study: 9842628

Group type: EXPERIMENTAL
Intervention: Binocular viewing conditions
Number of subjects: 30

Group type: COMPARATOR
Intervention: Monocular viewing conditions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Static environmental structure
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dynamic environmental structure
Number of subjects: 30
Study: 8206771

Group type: EXPERIMENTAL
Intervention: Procedural‐sensory modeling video treatment
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Procedural modeling video treatment
Number of subjects: 145

Group type: COMPARATOR
Intervention: Videotaped procedural modeling information
Number of subjects: 145

Group type: COMPARATOR
Intervention: Videotaped procedural‐sensory modeling information
Number of subjects: 145

Group type: COMPARATOR
Intervention: Procedural‐sensory information booklet
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 145
Study: 2913765

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30121127

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic surgery (SILS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional laparoscopy (CLS)
Number of subjects: 23
Study: 28063907

Group type: EXPERIMENTAL
Intervention: Standard curriculum plus weekly video coaching by an expert laparoscopic surgeon
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard simulation curriculum
Number of subjects: 20
Study: 24496325

Group type: EXPERIMENTAL
Intervention: Radial compression device (TR Band, Terumo Medical, Tokyo, Japan)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Chitosan‐based pad (Anscare, Daxon, Taoyuan, Taiwan)
Number of subjects: 600
Study: 24460292

Group type: EXPERIMENTAL
Intervention: Breast Self-Examination (BSE)
Number of subjects: 52011

Group type: EXPERIMENTAL
Intervention: Clinical Breast Examination (CBE)
Number of subjects: 52011

Group type: EXPERIMENTAL
Intervention: Referral for further investigations
Number of subjects: 52011
Study: 22053537

Group type: EXPERIMENTAL
Intervention: Dance training group (DTG; N = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (CG; N = 60)
Number of subjects: 120
Study: 19196468

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral dihydrocodeine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Follow-up at 1, 3, and 6 months post detoxification
Number of subjects: 90
Study: 16538135

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% ophthalmic emulsion (Restasis) twice per day
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rewetting drops (carboxymethylcellulose 0.5%, Refresh Contacts) twice per day
Number of subjects: 17
Study: 12639595

Group type: EXPERIMENTAL
Intervention: Adherence counseling
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Grades
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Being bicultural
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Risk behaviors
Number of subjects: 286
Study: 12545629

Group type: COMPARATOR
Intervention: 10 cc of 2% lidocaine gel in the endorectal (group 1)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 10 cc of 1% lidocaine solution injected into the apex (group 2)
Number of subjects: 96
Study: 9798805

Group type: EXPERIMENTAL
Intervention: L plus clarithromycin (C) 250 mg b.d. plus tinidazole (T) 500 mg b.d. for 7 days (LCT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: RBC plus C 250 mg b.d. and T 500 mg b.d. for 7 days (RbcCT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: LCT and RbcCT
Number of subjects: 112
Study: 7617820

Group type: EXPERIMENTAL
Intervention: 50 mg/70 kg intravenous diphenhydramine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study: 2144153

Group type: EXPERIMENTAL
Intervention: Quadrantectomy plus external radiotherapy
Number of subjects: 705

Group type: COMPARATOR
Intervention: Lumpectomy plus external and interstitial radiotherapy
Number of subjects: 705
Study: 667190

Group type: EXPERIMENTAL
Intervention: Accurate feedback of skin resistance level changes
Number of subjects: 36

Group type: COMPARATOR
Intervention: Inaccurate feedback of skin resistance level changes
Number of subjects: 36
Study: 30548529

Group type: EXPERIMENTAL
Intervention: Immediate Catheter Removal (ICR)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Delayed Catheter Removal (DCR)
Number of subjects: 155
Study: 28245280

Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention delivered by community health workers (16 home visits from third trimester to 6 months postpartum)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention for short allele carriers
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Maternal-infant attachment intervention for long allele carriers
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Intervention group with short allele
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Intervention group with long allele
Number of subjects: 220
Study: 25381468

Group type: EXPERIMENTAL
Intervention: Biofix(®) arrows
Number of subjects: 46

Group type: COMPARATOR
Intervention: FasT‐Fix(®) suture devices
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Reoperated patients
Number of subjects: 46
Study: 23237788

Group type: EXPERIMENTAL
Intervention: Green tea (1600 mg EGCG and 600 mg caffeine)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 21815857

Group type: EXPERIMENTAL
Intervention: Rhythmic Stepping Exercise (RSE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-Rhythmic Stepping Exercise (NRSE)
Number of subjects: 52
Study: 19363633

Group type: EXPERIMENTAL
Intervention: Unilateral deep brain stimulation (DBS) in globus pallidus (GPi)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Unilateral deep brain stimulation (DBS) in subthalamic nucleus (STN)
Number of subjects: 42
Study: 16460562

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (500 micrograms twice daily)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol combination (500/50 micrograms twice daily)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 15851196

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD) therapy
Number of subjects: 4450

Group type: COMPARATOR
Intervention: No ICD therapy
Number of subjects: 4450

Group type: EXPERIMENTAL
Intervention: Seasonal variation in mortality
Number of subjects: 4450

Group type: EXPERIMENTAL
Intervention: High-risk season variable (spring in the north and winter in the south)
Number of subjects: 4450
Study: 11782265

Group type: EXPERIMENTAL
Intervention: Stabilization training combined with dynamic resistance training (group 2, n=20)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Stabilization training combined with dynamic‐static resistance training (group 3, n=20)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Stabilization training (group 1, n=19)
Number of subjects: 59
Study: 9265916

Group type: COMPARATOR
Intervention: Olanzapine 10 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study: 8497434

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg twice daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acipimox 600 mg twice daily
Number of subjects: 24
Study: 30379302

Group type: EXPERIMENTAL
Intervention: Intervention group (multicomponent intervention program)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 290
Study: 27712774

Group type: EXPERIMENTAL
Intervention: CTO PCI (early PCI of the CTO)
Number of subjects: 304

Group type: COMPARATOR
Intervention: No CTO PCI (conservative treatment without PCI of the CTO)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: CTO PCI (in left anterior descending coronary artery subgroup)
Number of subjects: 304

Group type: COMPARATOR
Intervention: No CTO PCI (in left anterior descending coronary artery subgroup)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: CTO PCI
Number of subjects: 304

Group type: COMPARATOR
Intervention: No CTO PCI
Number of subjects: 304
Study: 25211216

Group type: EXPERIMENTAL
Intervention: MDRS (remote monitoring and control diabetes management system)
Number of subjects: 37

Group type: COMPARATOR
Intervention: SAP therapy (sensor-augmented pump therapy)
Number of subjects: 37
Study: 22854911

Group type: EXPERIMENTAL
Intervention: 5% lidocaine patch
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 60
Study: 20458045

Group type: EXPERIMENTAL
Intervention: Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide (IDD-ETC) every 2 weeks
Number of subjects: 1284

Group type: COMPARATOR
Intervention: Conventionally scheduled chemotherapy with epirubicin/cyclophosphamide followed by paclitaxel every three weeks
Number of subjects: 1284
Study: 18545193

Group type: EXPERIMENTAL
Intervention: Traditional weight training class (n = 27)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Hybrid weight training class (n = 25)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Online weight training class (n = 27)
Number of subjects: 79
Study: 15852994

Group type: EXPERIMENTAL
Intervention: Desflurane, fentanyl, and thiopental
Number of subjects: 42

Group type: COMPARATOR
Intervention: Propofol and remifentanil (TIVA group)
Number of subjects: 42
Study: 12589345

Group type: EXPERIMENTAL
Intervention: Omalizumab (≥0.016 mg/kg of IgE per 4 weeks)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 525

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 525
Study: 10547166

Group type: EXPERIMENTAL
Intervention: Remote intercessory prayer (prayer group), n = 466
Number of subjects: 990

Group type: COMPARATOR
Intervention: Usual care group, n = 524
Number of subjects: 990
Study: 8857563

Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporine microemulsion preconcentrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sandimmun (conventional formulation of cyclosporine)
Number of subjects: 0
Study: 1825969

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE2 and 75 micrograms gestodene (F)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE2 and 150 micrograms desogestrel (M)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Both groups (F and M)
Number of subjects: 83
Study: 6440740

Group type: EXPERIMENTAL
Intervention: Levonorgestrel 20 mcg/day device
Number of subjects: 1509

Group type: COMPARATOR
Intervention: TCu 380Ag device
Number of subjects: 1509

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 1509
Study: 31707787

Group type: EXPERIMENTAL
Intervention: teen Mental Health First Aid
Number of subjects: 1605

Group type: COMPARATOR
Intervention: physical first aid
Number of subjects: 1605
Study: 30951589

Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment (ABT)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT)
Number of subjects: 189
Study: 30071866

Group type: EXPERIMENTAL
Intervention: Peer group intervention for HIV prevention and testing
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Implementation success measures (e.g., # of peer groups held)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Implementation process and factors related to success
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Effectiveness of the peer group intervention
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Feasibility, acceptability, and sustainability assessments
Number of subjects: 432
Study: 27445635

Group type: EXPERIMENTAL
Intervention: Navimed device for self-reporting pain
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard postoperative pain care
Number of subjects: 52
Study: 24646371

Group type: EXPERIMENTAL
Intervention: Ready to Act health education programme (n = 322)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Routine care (n = 187)
Number of subjects: 509
Study: 22530979

Group type: EXPERIMENTAL
Intervention: Combined Patient and Provider intervention
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Patient Only intervention
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Provider Only intervention
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Combined (Patient + Provider) intervention
Number of subjects: 860

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 860
Study: 19745172

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study: 17664952

Group type: EXPERIMENTAL
Intervention: Methotrexate plus sulfasalazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus chloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus cyclosporin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus leflunomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus intramuscular gold
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple DMARD therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate plus hydroxychloroquine
Number of subjects: 0
Study: 15023172

Group type: EXPERIMENTAL
Intervention: Botox (50 units)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dysport (150 units)
Number of subjects: 100
Study: 11666125

Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg thrice daily (Group A)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TTFCA 30 mg thrice daily (Group B)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (Group C)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TTFCA 60 mg thrice daily (Group D - normal subjects)
Number of subjects: 62
Study: 9677501

Group type: EXPERIMENTAL
Intervention: Crystallized intelligence (WAIS-R subtests: information, comprehension, similarities)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fluid intelligence (WAIS-R subtests)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal controls (N=25)
Number of subjects: 25
Study: 8305420

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (CEE) plus 10 mg medroxyprogesterone acetate (MPA)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 0.625 mg CEE plus 5 mg MPA
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 0.625 mg CEE only
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 184
Study: 2729386

Group type: EXPERIMENTAL
Intervention: Anterior colporrhaphy
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Revised Pereyra procedure
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Burch retropubic urethropexy
Number of subjects: 107
Study: 5002115

Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 31102345

Group type: EXPERIMENTAL
Intervention: 5% methimazole
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4% hydroquinone
Number of subjects: 50
Study: 31203243

Group type: EXPERIMENTAL
Intervention: Exercise referral schemes enhanced by self-management strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardised scales (Marcus's Self‐Efficacy Questionnaire, Physical Activity Self‐Regulation Scale, Lubben Social Network Scale)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative findings
Number of subjects: 0
Study: 27412706

Group type: EXPERIMENTAL
Intervention: LGG‐TMC0356‐fermented milk for 10 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 25
Study: 26134881

Group type: EXPERIMENTAL
Intervention: Measurement-based care (MBC)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 304
Study: 22583681

Group type: EXPERIMENTAL
Intervention: Herbal mouthrinse (HM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse (EO)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouthrinse (CHX)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 48
Study: 20418523

Group type: EXPERIMENTAL
Intervention: BoNT‐A (500 U Dysport) injection
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo injection (saline)
Number of subjects: 24
Study: 19473511

Group type: EXPERIMENTAL
Intervention: On-line writing workshop group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard writing guidance training
Number of subjects: 48
Study: 16452593

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 15

Group type: COMPARATOR
Intervention: Air exposure (control)
Number of subjects: 15
Study: 15325934

Group type: EXPERIMENTAL
Intervention: Edaravone administration before myocardial reperfusion
Number of subjects: 80
Study: 11465759

Group type: EXPERIMENTAL
Intervention: Music intervention during cerebral angiography
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 30
Study: 10193989

Group type: EXPERIMENTAL
Intervention: Gortex membrane (GM)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Control group (pericardium left open)
Number of subjects: 302
Study: 8058353

Group type: EXPERIMENTAL
Intervention: Baclofen administration (10 subjects)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Baclofen administration (12 subjects)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (12 subjects)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (9 subjects)
Number of subjects: 43
Study: 3190004

Group type: EXPERIMENTAL
Intervention: Tubeless group (subgroup A) - operated on without any NG tube
Number of subjects: 150

Group type: COMPARATOR
Intervention: Subgroup B - NG tube inserted after induction of anesthesia and removed one hour after the operation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Subgroup C - NG tube inserted after induction of anesthesia and removed 12 hours after the operation
Number of subjects: 150
Study: 808194

Group type: EXPERIMENTAL
Intervention: Isotonic 5 percent crystalline amino acid solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dextrose in water
Number of subjects: 50
Study: 30779716

Group type: EXPERIMENTAL
Intervention: 5 sets per muscle group per session (G5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 sets per muscle group per session (G10)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 15 sets per muscle group per session (G15)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20 sets per muscle group per session (G20)
Number of subjects: 40
Study: 29320912

Group type: EXPERIMENTAL
Intervention: 6-second auditory hallucination simulation
Number of subjects: 82
Study: 25362103

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 56
Study: 24604289

Group type: EXPERIMENTAL
Intervention: 70 Gy radiation therapy with 6 months of androgen-suppression therapy (AST)
Number of subjects: 206

Group type: COMPARATOR
Intervention: 70 Gy radiation therapy without androgen-suppression therapy (AST)
Number of subjects: 206
Study: 22648253

Group type: EXPERIMENTAL
Intervention: Verteporfin photodynamic therapy (PDT)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of bevacizumab (IVB)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Transpupillary thermotherapy (TTT)
Number of subjects: 426
Study: 17598080

Group type: EXPERIMENTAL
Intervention: Endovenous laser therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiofrequency obliteration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic varicose vein operation
Number of subjects: 0
Study: 16290987

Group type: EXPERIMENTAL
Intervention: Abciximab (ABCX)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine (ADO)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 90
Study: 12016080

Group type: EXPERIMENTAL
Intervention: Dynamic magnetic resonance imaging of patellar tendinitis
Number of subjects: 51
Study: 10354809

Group type: EXPERIMENTAL
Intervention: Movements made with elastic resistance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Movements made without elastic resistance
Number of subjects: 0
Study: 8950959

Group type: EXPERIMENTAL
Intervention: Salbutamol (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procaterol (P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenoterol (F)
Number of subjects: 0
Study: 2103529

Group type: EXPERIMENTAL
Intervention: Topical levobunolol treatment for four months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Untreated fellow eye (control)
Number of subjects: 10